Drug resistance and invasion in diffuse large B-cell lymphoma are mediated by Akt, 14-3-3ζ, and Vimentin

被引：0
|
作者：
Cherry, Evan M. [1 ]
Bayless, Kayla J. [1 ]
Maxwell, Steve A. [1 ]
机构：
[1] Texas A&M Hlth Sci Ctr, College Stn, TX USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-702
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
702
引用
收藏
页数：1
相关论文
共 50 条
  • [41] AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma
    Wang, Jinfen
    Xu-Monette, Zijun Y.
    Jabbar, Kausar J.
    Shen, Qi
    Manyam, Ganiraju C.
    Tzankov, Alexandar
    Visco, Carlo
    Wang, Jing
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Tam, Wayne
    Bhagat, Govind
    Hsi, Eric D.
    van Krieken, J. Han
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Wang, Shi
    Moller, Michael B.
    Piris, Miguel A.
    Medeiros, L. Jeffrey
    Li, Yong
    Pham, Lan V.
    Young, Ken H.
    AMERICAN JOURNAL OF PATHOLOGY, 2017, 187 (08): : 1700 - 1716
  • [42] SCALP INVASION OF DIFFUSE LARGE B-CELL LYMPHOMA WITHOUT SYSTEMIC INVOLVEMENT
    Hasturk, A. E.
    Eyupoglu, E. E.
    Gel, G.
    Gokce, C.
    NEURO-ONCOLOGY, 2019, 21 : 69 - 69
  • [43] TCF3 and ID3 Expression in Diffuse Large B-cell Lymphoma in Burkitt Lymphoma
    Mroz, Pawel
    Singhal, Rashi L.
    Lim, Megan S.
    Wilcox, Ryan A.
    Keyoumarsi, Farah
    Fields, Kristina L.
    Bailey, Nathanael G.
    MODERN PATHOLOGY, 2016, 29 : 364A - 364A
  • [44] TCF3 and ID3 Expression in Diffuse Large B-cell Lymphoma in Burkitt Lymphoma
    Mroz, Pawel
    Singhal, Rashi L.
    Lim, Megan S.
    Wilcox, Ryan A.
    Keyoumarsi, Farah
    Fields, Kristina L.
    Bailey, Nathanael G.
    LABORATORY INVESTIGATION, 2016, 96 : 364A - 364A
  • [45] Mechanism and Treatment of Rituximab Resistance in Diffuse Large B-cell Lymphoma
    Zou, Linqing
    Song, Guoqi
    Gu, Siyu
    Kong, Lingling
    Sun, Shiqi
    Yang, Li
    Cho, William C.
    CURRENT CANCER DRUG TARGETS, 2019, 19 (09) : 681 - 687
  • [46] RituximabDevelopment of resistance in diffuse large B-cell lymphoma: case report
    Reactions Weekly, 2015, 1537 (1) : 226 - 226
  • [47] Quantitative Immunoshistochemistry Identifies B-Cell Receptor Signaling and AKT Activity in Diffuse Large B-Cell Lymphoma
    Bogusz, A. M.
    Baxter, R. H. G.
    Currie, T.
    Sinha, P.
    Kutok, J. L.
    Rodig, S. J.
    LABORATORY INVESTIGATION, 2012, 92 : 324A - 325A
  • [48] Quantitative Immunoshistochemistry Identifies B-Cell Receptor Signaling and AKT Activity in Diffuse Large B-Cell Lymphoma
    Bogusz, A. M.
    Baxter, R. H. G.
    Currie, T.
    Sinha, P.
    Kutok, J. L.
    Rodig, S. J.
    MODERN PATHOLOGY, 2012, 25 : 324A - 325A
  • [49] Cutaneous diffuse large B-cell lymphoma, leg type, secondary to testicular diffuse large B-cell lymphoma
    Pampin, A.
    Gomez-de la Fuente, E.
    Feltes, R. A.
    Pinedo, F.
    Rodriguez-Peralto, J. L.
    Lopez-Estebaranz, J. L.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014, 39 (02) : 230 - 232
  • [50] Combinatorial PI3K/AKT Pathway Inhibition As a Therapeutic Approach in Diffuse Large B-Cell Lymphoma
    Kupcova, Kristyna
    Senavova, Jana
    Herman, Vaclav
    Chrbolkova, Tereza
    Ondeckova, Iva
    Pacheco-Blanco, Mariana
    Havranek, Ondrej
    BLOOD, 2022, 140 : 3149 - 3150
12345